URL | https://www.reuters.com/business/healthcare-pharma |
Source | Reuters |
Date Published | 03/11/2025 |
Company/Division name | Merck |
Type of work | Manufacturing |
Reshoring category: | Reshoring |
Year reshoring announced: | 2025 |
Domestically, the work will be done: | In-house |
Capital investment ($): | 1000 |
City reshored to: | Durham |
State(s) reshored to: | NC |
If relevant, work nearshored to: | - |
Industry(ies): | Chemicals |
Product(s) reshored | pharmaceuticals |
What non-domestic negative factors made offshoring less attractive? | Tariffs |